New noninvasive ventilation strategy allows preterm infants to breathe freely

Preterm infants with respiratory distress syndrome (RDS) face heightened risks of death, critical illness, and prolonged hospitalization, particularly if they progress to develop acute respiratory distress syndrome (ARDS). A new study appearing in the journal Chest, published by Elsevier, suggests that treatment with nasal high-frequency oscillatory ventilation (NHFOV) is a beneficial management strategy in this population, and is superior to nasal continuous positive airway pressure (NCPAP) in preventing reintubation.

* This article was originally published here